Cited by 42Toxic Organic Pollutants ImpactCarcinogens and Genotoxicity AssessmentImmunotoxicology and immune responses

Liver Tumor Promotion by 2,3,7,8-Tetrachlorodibenzo-p-dioxin Is Dependent on the Aryl Hydrocarbon Receptor and TNF/IL-1 Receptors

Open access
Kennedy, Gregory D., Nukaya, Manabu, Moran, Susan M., Glover, Edward, Weinberg, Samuel, Balbo, Silvia, Hecht, Stephen S., Pitot, Henry C. +2 more·2014·Toxicological Sciences

Abstract

We set out to better understand the signal transduction pathways that mediate liver tumor promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxn ("dioxin"). To this end, we first employed congenic mice homozygous for either the Ahr(b1) or Ahr(d) alleles (encoding an aryl hydrocarbon receptor (AHR) with high or low binding affinity for dioxin, respectively) and demonstrated that hepatocellular tumor promotion in response to dioxin segregated with the Ahr locus. Once we had genetic evidence for the importance of AHR signaling, we then asked if tumor promotion by dioxin was influenced by "interleukin-1 (IL-1)-like" inflammatory cytokines. The importance of this question arose from our earlier observation that aspects of the acute hepatocellular toxicity of dioxin are dependent upon IL1-like cytokine signaling. To address this issue, we employed a triple knock-out (TKO) mouse model with null alleles at the loci encoding the three relevant receptors for tumor necrosis factors α and β and IL-1α and IL-1β (i.e., null alleles at the Tnfrsf1a, Tnfrsf1b, and Il-1r1 loci). The observation that TKO mice were resistant to the tumor promoting effects of dioxin in liver suggests that inflammatory cytokines play an important step in dioxin mediated liver tumor promotion in the mouse. Collectively, these data support the idea that the mechanism of dioxin acute hepatotoxicity and its activity as a promoter in a mouse two stage liver cancer model may be similar, i.e., tumor promotion by dioxin, like acute hepatotoxicity, are mediated by the linked action of two receptor systems, the AHR and the receptors for the "IL-1-like" cytokines.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/toxsci/kfu065

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • This mouse continues to be widely used as a nonresponsive control for studies examining the AHR-mediated effects of ligands like TCDD and BaP on common end points such as carcinogenesis and inflammation.

    “This mouse continues to be widely used as a nonresponsive control for studies examining the AHR-mediated effects of ligands like TCDD and BaP on common end points such as carcinogenesis and inflammation (Kennedy et al., 2014; Wong et al., 2018).”

    From Rodent Genetic Models of Ah Receptor Signaling (2021) · cites this paper as Kennedy et al., 2014

    The Animals section identifies the congenic Ahr d/d mouse as having a lower-affinity AHR, and the Discussion reports that it still showed dioxin-promoted tumors after 40 weeks. That contradicts describing it as a nonresponsive control without qualification. This paper studies TCDD-related liver tumor promotion, not BaP or the mouse’s widespread use. (LLM, conf=0.84)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured
  • Using the Ahrfx model can require high concentrations of ligands such as beta-naphthoflavone or highly potent ligands such as TCDD to elicit a response.

    “Thus, use of Ahrfx model can require high concentrations of certain ligands like beta-naphthoflavone (BNF) or the use of highly potent ligands like TCDD in order to illicit a response (Kennedy et al., 2014).”

    From Rodent Genetic Models of Ah Receptor Signaling (2021) · cites this paper as Kennedy et al., 2014

    The Animals section describes Ahr b1/b1 and Ahr d/d congenic mice, not an Ahrfx model. The Discussion reports a delayed tumor-promotion response to dioxin in Ahr d/d mice, but does not address whether Ahrfx requires high concentrations of beta-naphthoflavone or a potent ligand such as TCDD. Searches for Ahrfx, floxed Ahr, and beta-naphthoflavone found no passage addressing that claim; page numbers were unavailable in our copy. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. Drinkwater, N. R., and Denniston, C. (2011) Statistical Problems in Genet- ics and Molecular Biology, pp. 89-163. CreatSpace Independent Publishing Platform
  2. Giri, A. K. (1986). Mutagenic and genotoxic effects of 2,3,7,8- tetrachlorodibenzo-p-dioxin, a review. Mutat. Res. 168, 241-248.
  3. Nukaya, M., Moran, S., and Bradfield, C. A. (2009). The role of the dioxin- responsive element cluster between the Cyp1a1 and Cyp1a2 loci in aryl hy- drocarbon receptor biology. Proc. Natl. Acad. Sci. U.S.A. 106, 4923-4928.
  4. Walisser, J. A., Glover, E., Pande, K., Liss, A. L., and Bradfield, C. A. (2005). Aryl hydrocarbon receptor-dependent liver development and hepatotoxicity are mediated by different cell types. Proc. Natl. Acad. Sci. U.S.A. 102, 17858- 17863.

Cited by

Sorted by citations

Authors
Kennedy, G. D., Nukaya, M., Moran, S. M., Glover, E., Weinberg, S., Balbo, S., Hecht, S. S., Pitot, H. C., Drinkwater, N. R., & Bradfield, C. A.
Affiliations
  • University of Wisconsin–Madison (US)
  • University of Minnesota (US)
Venue
Toxicological Sciences
Published
2014-04-09
Volume
140
Issue
1
Pages
135-143
ISSN
  • 1096-0929 (ISSN-L)
  • 1096-6080
OpenAlex
W2169354960
Cited by
42
References
3
Citations by year
2025: 1 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 4 · 2020: 3 · 2019: 3 · 2018: 10 · 2017: 4 · 2016: 4 · 2015: 5 · 2014: 2
FWCI
3.29
Type
journal article
Language
en
Open access
Licence
public-domain
Locations
  • Toxicological Sciences (publishedVersion, public-domain)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (T32HL076139)
  • National Cancer Institute (P01CA022484, P30CA014520)
  • National Institute of Environmental Health Sciences (R01ES020668, K08ES017283)
Topics
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
Keywords
2,3,7,8-tetrachlorodibenzo-p-dioxin, dioxins, liver tumor promotion, hepatocellular carcinoma, aryl hydrocarbon receptor, TNF receptor, IL-1 receptor, inflammatory cytokines, AhR knockout mice, triple knockout mice, hepatotoxicity, signal transduction
MeSH terms
Animals, Caprylates, Cocarcinogenesis, Diethylnitrosamine, Dioxins, Liver Neoplasms, Experimental, Male, Mice, Inbred C57BL, Triglycerides, Receptors, Interleukin-1, Receptors, Tumor Necrosis Factor, Receptors, Aryl Hydrocarbon, Mice, Knockout

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review